Company Introduction
Micronova Pharmaceuticals Ind. Ltd. (MNPIL) is a trusted name in Nigeria’s pharmaceutical landscape. Since 2011, we have been delivering world-class medicines in selective therapy areas like Cardiology, Diabetology, Gastroenterology, Ophthalmology, OTC/OTX, Pain Management, Anti-infectives, Anti allergic and CNS therapy. As a subsidiary of Microlabs India, we leverage over 50 years of global pharmaceutical expertise and manufacturing excellence.
OUR JOURNEY IN NIGERIA
2011
Entered Nigeria with 5 products
2014
Two divisions launched: Prolife (Cardio) and Novacare (Ophthalmic & Diabetic)
2017
Third division V-Care (Gastro & Acute) established
2020
Origen (OTC/OTX) and digital strategy initiated
2022
Ranked as one of Nigeria's top premium pharma companies
2023
5 divisions, 200+ field force, 132+ NAFDAC registrations
2024
Aquisition of Swipha Pharma
OUR VISION
To be regarded as a state-of-the-art pharmaceutical company in terms of quality and customer satisfaction.
OUR MISSION
To provide quality medicines at competitive prices, anywhere in Nigeria and beyond.
OUR CORE VALUES
QUALITY
Our uncompromising foundation
ETHICS
Conducting business with integrity
CUSTOMER FOCUS
Understanding and delivering on healthcare needs
RESPECT FOR PEOPLE
Empowering teams and partners
INNOVATION
Driving progress through science